Global Digital Pathology Market worth USD 980.65 Million by 2024

The report "Global Digital Pathology Market - Trends Analysis, Company Usability Profiles & Forecasts to 2024", published by 360iResearch, states that the global market was valued at USD 360.53 million in 2016 and is projected to reach USD 980.65 million by 2024, growing at a CAGR of 13.32% from 2016 to 2024.

The major forces driving the growth of the digital pathology market include the quality improvement in service delivery and increasing prevalence of chronic disease. Moreover, technological advancement in healthcare is also one of the factors that is driving the market growth. However certain factors such as the high cost system and lack of standards may hinder the market growth. In the middle of difficulty lies opportunity such as the streamline drug development processes in discovery, pre-clinical and clinical trials, evolving technologies improve the pathologist’s workstation experience, and increasing use in education, research, and training. The possible challenges for the market growth are legal barriers and cultural resistance, and data management and storage challenges. But key players in the market are overcoming the challenges with continual improvement and innovation.

Based on end user, the global digital pathology market is studied across academic & research institutes, hospitals & care providers, laboratories, and pharmaceutical & biotechnology companies. Based on deployment, the global digital pathology market is studied across on-cloud, and on-premise. Based on geography, the global digital pathology market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.

The report features a competitive scenario of the digital pathology market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are 3DHISTECH Ltd, Corista LLC, DeepBio, Inc., Definiens, Inc., Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Inspirata, Inc., Leica Biosystems Nussloch Gmbh, OptraSCAN, Inc., Philips Healthcare, Proscia, Inc., Sectra AB, Ventana Medical Systems, Inc., and Visiopharm.

About 360iResearch

We at 360iResearch provide syndicated as well as customized reports along with short and long-term consulting services pertaining to your requirements; offering accurate analysis, post precise data mining and analysis of information gathered. Adding to that, our offerings also include customized data pack, proposing market sizing in a WEB/Excel/PDF/PPT/Word format as per the need of our consumers.

Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic move and take your company’s future ahead with our support and your esteemed cooperation. We help you take strategic business decisions across several industry verticals namely but not restricted to - Healthcare & Life Sciences and Information Technology. These application areas are further studied and analyzed across different geographies namely Americas, Europe, Middle East & Africa, and Asia-Pacific. We cover segment-wise market dynamics primarily on the regional level, wherein we analyze the regional DROC separately for each region to ensure accurate country-level forecast. Our top down and bottom up methodologies are rigorously followed in order to estimate the market and analyze the trends. This makes us distinct from others in the market.

We hold expertise in our designated areas of research and consulting with a team of experts from each of the dedicated areas covered under our research. We update our database regularly in order to provide you historical as well as the forecast database which would match your expectations. Our motto is to provide you a leading edge in our strategic analysis and this will help you stand among the leading players in your designated market.

Contact:
Miss. Shailee Sachan
Business Analyst,
B17-802, Nyati Elan,
Wagholi, Pune,
India - 412207.
USA: +1-415-325-3141
India: +91-9762827500
Email:[email protected]